FDA Launches SAFEKIDS Initiative with Academic and Clinical Partners The
FDA Launches SAFEKIDS Initiative with Academic and Clinical Partners
The Safety of Key Inhaled and Intravenous Drugs in Pediatrics (SAFEKIDS) Initiative is a multi-year project designed to address major gaps in scientific information about the safe use of anesthetics and sedatives received by millions of children each year.